Research led by Prasad Adusumilli focuses primarily on tumor immunology and the development of T-cell-mediated immunotherapy for thoracic malignancies and pleural-based diseases. In recent years, Dr. Adusumilli has devoted his efforts to study the tumor immune microenvironment in thoracic malignancies and developing mesothelin-targeted immunotherapy for malignant pleural mesothelioma and lung cancer.

Selected Achievements

Department of Defense (DoD) Technology/Therapeutic Development Award (2011-2014) 

Department of Defense (DoD) Lung Cancer Promising Clinician Research Award (2012)

American Association for Thoracic Surgery (AATS) Third Edward D. Churchill Research Scholarship (2009)

International Association for Study of Lung Cancer (IASLC) Young Investigator Award (2008)